Purchase this article with an account.
Alejandra de-la-Torre, Elizabeth Torres- Morales, Laura Taborda, Nestor I Cardona, Juan C sepúlveda-Arias, Manuel A Patarroyo, Jorge E Gomez-Marin, ; Peripheral immune response in human toxoplasmosis depends on clinical condition but not on the antigen. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5280.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
The peripheral immune response is incompletely known in human toxoplasmosis. We aimed to study this response and the cytokine production regarding P30 and ROP 18 protein-derived Toxoplasma peptides.
The specific lymphocyte proliferative response and cytokine profile production regarding Toxoplasma P30 (2017 from virulent and non-virulent strain) and ROP18 protein-derived peptides (from clonal lineages I, II and III) were determined in 19 patients having ocular toxoplasmosis, five suffering chronic asymptomatic infection, 9 with congenital toxoplasmosis and 8 Toxoplasma negative people. A Beckman-Coulter FC500n flow cytometer was used for determining antigen-specific T-cells (CD3+CD4+ or CD3+CD8+ cells) in peripheral blood culture. IFNg and IL10 levels were determined in culture supernatants.
Specific CD4+ and CD8+ T-cell response to total antigen and P30- and ROP18-derived peptides was observed in infected people. Ocular toxoplasmosis patients had a preferential Th2 response after antigenic stimulation. Non-virulent peptide 2017 was able to shift response towards Th1 in congenitally-infected children and virulent peptide 2017 induced a Th2 response in chronically-infected, asymptomatic people.
An immune response in human toxoplasmosis after ex vivo antigenic stimulation was Th1- or Th2-skewed, depending on a patient’s clinical condition. Colombian ocular toxoplasmosis patients’ immune response was Th2-skewed, regardless of the nature of antigen stimulus.
This PDF is available to Subscribers Only